Analysis of assortiment of medicines for the treatment of benign prostate diseases for the evaluation of particular marketing opportunities for domestic manufacturers

Authors

DOI:

https://doi.org/10.15587/2519-4852.2017.93892

Keywords:

pharmaceutical market, medicines, diseases of the prostate, marketing research

Abstract

Distribution of urological diseases such as prostatitis and prostatic hyperplasia leads to deterioration of physical and psychological health of the working population of our country, which ultimately affects (in a macroeconomic sense) the ability to produce gross national product, increases the amount of payments for medical sick-leave certificate. In connection with the above mentioned the search for new treatment regimens of these diseases are urgent issues of modern medicine and the development of new drugs remains a burning issue for the national pharmacy. Therefore, it is appropriate to determine the state of the market, trends in the consumption of drugs to treat these diseases. Our studies are the basis for the rationale for finding, developing and bringing to market innovative drugs.

The aim was to study the structure and trends of the Ukrainian market of medicines for the prevention and treatment of benign prostate diseases to identify marketing opportunities for domestic pharmacy.

Materials and methods. The study was conducted with using structural analysis, logical and graphical methods as well as methods of marketing analysis.

Results. Were detected the dynamics of changes and trends of Ukrainian pharmaceutical market of that group. Market structure revealed by the number of names, brands, the forms of production, producing countries and its composition. The results show that over the past 15 years the number of registered drugs of this group decreased, but increased the number of offers from domestic producers. Still, the structure of the market is depended from import - drugs from foreign origins occupy about 70% of the domestic market and the range of more than 78% in terms of implementation. Market drugs for the treatment of benign prostate disease has a positive trend in both sales volume dynamics and the structure of the range. For the overall results in 2016 it is indicated an increase in sales of goods "Pharmaceutical basket" in monetary terms.

Conclusions. Based on the detected changes were developed some proposals for the domestic pharmaceutical industry - the market is relatively limited supply of domestic complex drugs that are composed of plant material, because the development and output of innovative drugs is a promising area of development.

Author Biographies

Volodymyr Zaychenko, National University of Pharmacy Pushkinska str., 53, Kharkiv, Ukraine, 61002

Postgraduate student

Department of Industrial Technology of Drugs

Olena Ievtushenko, National University of Pharmacy Pushkinska str., 53, Kharkiv, Ukraine, 61002

Doctor of Pharmaceutical Sciences, Professor

Department of Pharmaceutical Marketing and Management 

Оlena Ruban, National University of Pharmacy Pushkinska str., 53, Kharkiv, Ukraine, 61002

Doctor of pharmaceutical sciences, Professor

Department of Industrial Technology of Drugs

Julia Masliy, National University of Pharmacy Pushkinska str., 53, Kharkiv, Ukraine, 61002

PhD, associate professor

Department of Industrial Technology of Drugs

Tymur Ravshanov, National University of Pharmacy Pushkinska str., 53, Kharkiv, Ukraine, 61002

Postgraduate student

Department of clinical pharmacology IPHPQI

References

  1. Zajchenko, A. V., Tac'kij, Ju. O., Korotkov, V. A., Kovalenko, E. N., Andrijanenkov, A. V., Kuhtenko, A. S. (2014). Morfologicheskaja ocenka prostatoprotektornogo dejstvija svechej s masljannym ekstraktom makljury v jeksperimente. Jeksperimental'naja i klinicheskaja urologija, 2, 28–31.
  2. Vyshnevs'ka, L. I. (2009). Farmakoekonomichna ocinka likars'kyh preparativ dlja likuvannja zahvorjuvan' peredmihurovoi' zalozy na farmacevtychnomu rynku Ukrai'ny. Klinichna farmacija, 13 (1), 37–40.
  3. Dmytrijevskyj, D. I., Kobec, M. M., Kobec, Ju. M., Ahmedov, E. Ju., Harkova, Ju. O. (2012). Marketyngovi doslidzhennja preparativ prostatoprotektoriv, predstavlenyh na farmacevtychnomu rynku Ukrai'ny. Visnyk farmacii, 3 (71), 28–31.
  4. Soldatova, Je. O. (2015). Farmakologichne doslidzhennja prostatoprotektornoi dii' supozytorii'v z fito ekstraktamy. Kharkiv, 22.
  5. Listopad, O. (2000). Preparaty, ispol'zuemye pri adenome predstatel'noj zhelezy: sovremennyj assortiment, ceny, tendencii na rynke. Provizor, 8. Available at: http://www.provisor.com.ua/archive/2000/N8/listop.php
  6. Shevina, V. L., Hohlenkova, N. V., Jarnyh, T. G. (2014). Analiz vitchyznjanogo farmacevtychnogo rynku likars'kyh zasobiv, shho zastosovujut'sja dlja likuvannja sechokam’janoi' hvoroby. Aktualni pytannja farmacevtychnoi i medychnoi nauky ta praktyky, 3 (16), 88–91.
  7. Baza danih «Ekvalajzer» TOV «Bіznes-Kredit». EQ. Available at: http://eq.bck.com.ua/
  8. Derzhavnyj rejestr likarskyh zasobiv Ukrainy. MOZ Ukrainy. Available at: http://www.drlz.com.ua/
  9. Kompendium: lekarstvennye preparaty. Available at: http://compendium.com.ua/
  10. Kirsanov, D. (2016). Brif-analiz farmrynka: itogi nojabrja 2016. Ezhenedelnik «Apteka», 1067 (46). Available at: http://www.apteka.ua/article/397246
  11. Eliseeva, I. I. (2004). Obshhaja teorija statistiki. Moscow: Finansy i statistika, 656.
  12. Volyk, I. M. (2006). Statystyka. Chastyna 3: Indeksy. Sumy: UABS NBU, 26.
  13. Dmitrik, E. (2016). Aptechnye prodazhi v regionah Ukrainy po itogam 9 mesjacev 2016 g. Ezhenedel'nik «Apteka», 1063 (42). Available at: http://www.apteka.ua/article/389281

Published

2017-02-28

How to Cite

Zaychenko, V., Ievtushenko, O., Ruban О., Masliy, J., & Ravshanov, T. (2017). Analysis of assortiment of medicines for the treatment of benign prostate diseases for the evaluation of particular marketing opportunities for domestic manufacturers. ScienceRise: Pharmaceutical Science, (1 (5), 53–61. https://doi.org/10.15587/2519-4852.2017.93892

Issue

Section

Pharmaceutical Science